| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1770 | Diabzi Sting Agonist-3 | Novel potent and selective STING agonist, activating secretion of IFNβ, IL-6, TNF, and KC/GROα, exhibiting durable anti-tumour effects |
|
| DCC1771 | Diafluo | Novel probe for protein S-sulfinylation from cells |
|
| DCC1772 | Dianicline | Selective alpha4beta2 nAChR partial agonist for the treatment of nicotine dependence to assist in smoking cessation |
|
| DCC1773 | Diazaborine | Novel Inhibitor of the AAA-ATPase Drg1, blocking ribosome biogenesis |
|
| DCC1774 | Diazoline | Histamine H1-receptor antagonist |
|
| DCC1775 | Dibromo-morin | Morin derivative, enhancing neural glyoxalase pathway (GP) activity and preventing methylglyoxal-mediated oxidative stress (OS) in an AD model |
|
| DCC1776 | Diclofenac Acyl Glucuronide | Major biliary metabolite of Diclofenac, a nonsteroidal antiinflammatory drug and COX inhibitor |
|
| DCC1777 | Diclofenac Potassium | Non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions |
|
| DCC1778 | Diclosulam | Selective herbicide for the control of dicot weeds |
|
| DCC1779 | Did Perchlorate Featured | Lipophilic fluorescent reagent, labeling membranes and other hydrophobic structures |
|
| DCC1780 | Didehydro-cortistatin A | Natural Tat inhibitor, blocking HIV-1 transcription by specifically targeting the viral transactivator, Tat |
|
| DCC1781 | Dids Sodium Salt | Inhibitor of DTDST inhibitor, a novel intestinal epigallocatechin gallate (EGCg) transporter |
|
| DCC1782 | Diethyl Bipy55'dc | Novel inhibitor of CP4H activity in cultured cells at concentrations that do not cause iron deficiency |
|
| DCC1783 | Diethyl Pyimdc | Novel inhibitor of CP4H activity in cultured cells at concentrations that do not cause iron deficiency |
|
| DCC1784 | Diethylcarbamazine Citrate | Muscle relaxant, causing general central nervous system depression, relieving pain caused by strains, sprains, and other musculoskeletal conditions |
|
| DCC1785 | Difenidol | Antiemetic agent used in the treatment of vomiting and vertigo |
|
| DCC1786 | Difeterol | Agonist of the androgen receptor (AR); #333333; font-family: "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: |
|
| DCC1787 | Diflorasone | Corticosteroid Hormone Receptor Agonist |
|
| DCC1788 | Dihydralazine | Novel dose-dependent inhibitor of the SARS-CoV-2 Mac1 Macrodomain |
|
| DCC1789 | Dihydrexidine Hydrochloride | D1-like full agonist with similar affinity for D1 and D5, and roughly 10-fold selectivity over D2-like receptors |
|
| DCC1790 | dihydro-beta-erythroidine Hydrobromide | Competitive nicotinic receptor antagonist |
|
| DCC1791 | Dihydrocyclosporin A | Closely related co-metabolite of cyclosporin A |
|
| DCC1792 | Dihydromotuporamine C Trihydrochloride | Unique antimigration and antiangiogenic agent |
|
| DCC1793 | Diic16tac | Novel lipid-based, high-density, environmentally sensitive (HIDE) probe |
|
| DCC1794 | Diic16'tco | Novel lipid-based, high-density, environmentally sensitive (HIDE) probe |
|
| DCC1795 | Dilazep | Vasodilator for the treatment of cardiopathy and renal disorders, acting as an adenosine reuptake inhibitor. |
|
| DCC1796 | Dimenthyl (1s,2s)-cyclopropane-1,2-dicarboxylate | Building Block |
|
| DCC1797 | Dimenthyl Succinate | Building Block |
|
| DCC1798 | dimethacrine | Novel inhibitor of AMA1-RON2 interaction, blocking merozoite invasion from schizont-infected RBCs; Antidepressant; Acetylcholinesterase inhibitor |
|
| DCC1799 | Dimethothiazine | Serotonin antagonist and histamine antagonist |
|
